WallStSmart

Agilent Technologies Inc (A)vsQuest Diagnostics Incorporated (DGX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Quest Diagnostics Incorporated generates 61% more annual revenue ($11.84B vs $7.37B). A leads profitability with a 19.5% profit margin vs 9.5%. A appears more attractively valued with a PEG of 1.47. DGX earns a higher WallStSmart Score of 64/100 (C+).

A

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.5Value: 4.0Quality: 6.0
Piotroski: 3/9Altman Z: 1.99

DGX

Buy

64

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 4.0Quality: 6.5
Piotroski: 5/9Altman Z: 2.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASignificantly Overvalued (-63.8%)

Margin of Safety

-63.8%

Fair Value

$78.68

Current Price

$171.99

$93.31 premium

UndervaluedFair: $78.68Overvalued
DGXSignificantly Overvalued (-87.2%)

Margin of Safety

-87.2%

Fair Value

$111.82

Current Price

$250.81

$138.99 premium

UndervaluedFair: $111.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

A2 strengths · Avg: 8.5/10
Market CapQuality
$51.17B9/10

Large-cap with strong market position

Operating MarginProfitability
25.6%8/10

Strong operational efficiency at 25.6%

DGX1 strengths · Avg: 8.0/10
EPS GrowthGrowth
28.7%8/10

Earnings expanding 28.7% YoY

Areas to Watch

A3 concerns · Avg: 3.7/10
P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

DGX1 concerns · Avg: 4.0/10
PEG RatioValuation
1.584/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : A

The strongest argument for A centers on Market Cap, Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bull Case : DGX

The strongest argument for DGX centers on EPS Growth.

Bear Case : A

The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.

Bear Case : DGX

The primary concerns for DGX are PEG Ratio.

Key Dynamics to Monitor

A profiles as a mature stock while DGX is a value play — different risk/reward profiles.

A carries more volatility with a beta of 1.21 — expect wider price swings.

DGX is growing revenue faster at 10.0% — sustainability is the question.

DGX generates stronger free cash flow (574M), providing more financial flexibility.

Bottom Line

DGX scores higher overall (64/100 vs 63/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agilent Technologies Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.

Quest Diagnostics Incorporated

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Want to dig deeper into these stocks?